Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
ONNVF
)
1.190
+0.090 (+8.18%)
Streaming Delayed Price
Updated: 3:25 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,000
Open
1.190
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.100
Today's Range
1.190 - 1.190
52wk Range
0.8000 - 3.200
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Today 3:00 EST
Via
ACCESS Newswire
Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
November 25, 2025
Via
ACCESS Newswire
Performance
YTD
-14.4%
-14.4%
1 Month
N/A
N/A
3 Month
-9.8%
-9.8%
6 Month
-62.8%
-62.8%
1 Year
-14.4%
-14.4%
More News
Read More
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
November 20, 2025
Via
ACCESS Newswire
Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
November 18, 2025
Via
ACCESS Newswire
Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment
November 07, 2025
Via
ACCESS Newswire
Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight
October 31, 2025
Via
ACCESS Newswire
Onco-Innovations Appoints Jared Rushton to Board of Directors
October 30, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Closing of Private Placement
October 27, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Private Placement
October 14, 2025
Via
ACCESS Newswire
Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
September 29, 2025
Via
ACCESS Newswire
Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
September 22, 2025
Via
ACCESS Newswire
Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
September 19, 2025
Via
ACCESS Newswire
Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care
September 12, 2025
Via
ACCESS Newswire
Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
September 05, 2025
Via
ACCESS Newswire
Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised
August 15, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Closing of Private Placement
August 13, 2025
Via
ACCESS Newswire
Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
August 04, 2025
Via
ACCESS Newswire
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
July 31, 2025
From
OneMedNet Corporation
Via
GlobeNewswire
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
July 30, 2025
Via
ACCESS Newswire
Onco-Innovations Announces Private Placement
July 29, 2025
Via
ACCESS Newswire
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
July 21, 2025
Via
ACCESS Newswire
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
July 11, 2025
Via
ACCESS Newswire
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
July 10, 2025
Via
ACCESS Newswire
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
July 04, 2025
Via
ACCESS Newswire
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
July 02, 2025
Via
ACCESS Newswire
Frequently Asked Questions
Is ONNVF publicly traded?
Yes, ONNVF is publicly traded.
What exchange does ONNVF trade on?
ONNVF trades on the OTC Traded
What is the ticker symbol for ONNVF?
The ticker symbol for ONNVF is ONNVF on the OTC Traded
What is the current price of ONNVF?
The current price of ONNVF is 1.190
When was ONNVF last traded?
The last trade of ONNVF was at 12/05/25 03:25 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.